Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and fluphenazine

erlotinib hydrochloride has been researched along with fluphenazine in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(fluphenazine)		Trials
(fluphenazine)		Recent Studies (post-2010) (fluphenazine)
4,3537863,0332,494400130

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)fluphenazine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.067
Potassium channel subfamily K member 2Homo sapiens (human)4.7
Tyrosine-protein kinase FynHomo sapiens (human)7.99
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)1.962
Muscarinic acetylcholine receptor M2Homo sapiens (human)7.481
Muscarinic acetylcholine receptor M4Homo sapiens (human)3.468
ATP-dependent translocase ABCB1Homo sapiens (human)6.1
Alpha-2A adrenergic receptorHomo sapiens (human)0.215
Muscarinic acetylcholine receptor M1Homo sapiens (human)2.683
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)5.7058
D(2) dopamine receptorHomo sapiens (human)0.0016
Alpha-2B adrenergic receptorHomo sapiens (human)0.029
Alpha-2C adrenergic receptorHomo sapiens (human)0.154
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)1.644
Muscarinic acetylcholine receptor M3Homo sapiens (human)4.728
D(1A) dopamine receptorHomo sapiens (human)0.023
D(4) dopamine receptorHomo sapiens (human)5.877
Sodium-dependent noradrenaline transporter Homo sapiens (human)1.962
Histamine H2 receptorHomo sapiens (human)1.226
Alpha-1D adrenergic receptorHomo sapiens (human)0.033
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0051
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.067
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)1.644
Sodium-dependent serotonin transporterHomo sapiens (human)1.492
Melanocortin receptor 5Homo sapiens (human)9.518
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C1.7
Histamine H1 receptorHomo sapiens (human)0.04
D(3) dopamine receptorHomo sapiens (human)0.0006
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.039
5-hydroxytryptamine receptor 6Homo sapiens (human)0.052
Sodium-dependent dopamine transporter Homo sapiens (human)2.053
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)5.7058
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)5.7058
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aldape, K; Cheng, K; Ruppin, E; Schäffer, AA; Schiff, E; Sinha, S1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and fluphenazine

ArticleYear
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
    Molecular systems biology, 2020, Volume: 16, Issue:7

    Topics: A549 Cells; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Design; Drug Evaluation, Preclinical; Erlotinib Hydrochloride; Fluphenazine; HEK293 Cells; Humans; Kidney; Lung; MCF-7 Cells; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Systems Biology; Up-Regulation; Vemurafenib

2020